Clinical Trials Directory

Explore 21,535 clinical trials worldwide

Showing 18001-18050 of 21,535 trials

Active filters:Status: Active, not recruiting

Clinical Trials (21,535)

NCT03186118
Pilot Study of T-APCs Following CAR T Cell Immunotherapy for CD19+ Leukemia
PHASE1Active, not recruiting
30 participants
Started: Aug 4, 2017 · Completed: Jul 31, 2033
1 condition1 sponsor1 location
NCT03206671
Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents
PHASE3Active, not recruiting
650 participants
Started: Aug 3, 2017 · Completed: Jun 30, 2027
1 condition2 sponsors88 locations
NCT03179904
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
PHASE2Active, not recruiting
19 participants
Started: Aug 3, 2017 · Completed: Dec 31, 2025
5 conditions1 sponsor3 locations
NCT02935517
Safety and Efficacy Trial of AAV Gene Therapy in Patients With CNGA3 Achromatopsia (A Clarity Clinical Trial)
PHASE1/PHASE2Active, not recruiting
24 participants
Started: Aug 3, 2017 · Completed: Aug 31, 2026
1 condition1 sponsor6 locations
NCT02883062
Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer
PHASE2Active, not recruiting
67 participants
Started: Aug 2, 2017 · Completed: Sep 11, 2026
4 conditions1 sponsor14 locations
NCT03217747
Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
PHASE1/PHASE2Active, not recruiting
173 participants
Started: Aug 2, 2017 · Completed: Apr 30, 2026
10 conditions2 sponsors1 location
NCT03199469
A Study of AT132 in Young Children With X-Linked Myotubular Myopathy (XLMTM)
PHASE2/PHASE3Active, not recruiting
27 participants
Started: Aug 2, 2017 · Completed: Mar 31, 2030
1 condition1 sponsor6 locations
NCT04384913
Kinematic Versus Mechanical Alignment in Total Knee Replacement
N/AActive, not recruiting
130 participants
Started: Aug 1, 2017 · Completed: Jan 30, 2026
1 condition1 sponsor1 location
NCT03946410
Danish Cardiovascular Screening Trial II
NAActive, not recruiting
38,000 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2027
2 conditions2 sponsors4 locations
NCT03162432
High Dose Interval Vitamin D Supplementation in Patients With IBD Receiving Remicade
PHASE3Active, not recruiting
50 participants
Started: Aug 1, 2017 · Completed: Dec 1, 2023
3 conditions1 sponsor1 location
NCT03377647
An Asthma Collaboration to Reduce Childhood Asthma Disparities on the Navajo Nation
NAActive, not recruiting
300 participants
Started: Aug 1, 2017 · Completed: Jun 30, 2025
1 condition2 sponsors2 locations
NCT07147452
Sentinel Lymph Node Detection in Gastric Cancer Using a Dual Tracer (Superparamagnetic Iron Oxide and Methylene Blue): A Prospective Study With Histological and OSNA Validation
N/AActive, not recruiting
44 participants
Started: Aug 1, 2017 · Completed: Aug 31, 2025
2 conditions2 sponsors1 location
NCT03505983
Criteria for Advanced Prosthetic Foot Prescription
NAActive, not recruiting
91 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
2 conditions4 sponsors1 location
NCT04737525
Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement
NAActive, not recruiting
50 participants
Started: Aug 1, 2017 · Completed: Feb 10, 2031
1 condition2 sponsors1 location
NCT03223766
Evaluation of Proton Therapy in Pediatric Cancer Patients
N/AActive, not recruiting
1,000 participants
Started: Aug 1, 2017 · Completed: Jul 31, 2037
1 condition1 sponsor1 location
NCT03408106
Prospective Clinical Trial of HIV+ Living Donor Kidney Donation for HIV+ Recipients
N/AActive, not recruiting
20 participants
Started: Aug 1, 2017 · Completed: Aug 1, 2030
1 condition1 sponsor2 locations
NCT03031912
African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
PHASE2Active, not recruiting
250 participants
Started: Aug 1, 2017 · Completed: Feb 28, 2025
1 condition6 sponsors1 location
NCT03199729
Aging and Mixed Perturbation Training to Reduce Falls in Locomotion
NAActive, not recruiting
600 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT03222531
Expanding the Pool in Orthotopic Heart Transplantation
PHASE2Active, not recruiting
20 participants
Started: Aug 1, 2017 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT03043716
Long-term Observation of PAP-therapy With Telemonitoring: Telemedicine Registry TelePAP
N/AActive, not recruiting
14,147 participants
Started: Aug 1, 2017 · Completed: Dec 31, 2025
3 conditions2 sponsors6 locations
NCT03238755
Mechanisms of Cardiac Dysfunction in HIV and the Effect of Statins: a Cardiac MRI Study
N/AActive, not recruiting
129 participants
Started: Jul 31, 2017 · Completed: Apr 23, 2026
1 condition3 sponsors4 locations
NCT03155620
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)
PHASE2Active, not recruiting
1,376 participants
Started: Jul 31, 2017 · Completed: May 9, 2026
45 conditions1 sponsor172 locations
NCT04312672
Long-term Follow-up Gene Therapy Study for RPGR- XLRP
N/AActive, not recruiting
42 participants
Started: Jul 31, 2017 · Completed: Nov 18, 2026
1 condition1 sponsor5 locations
NCT03247088
Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant
PHASE1/PHASE2Active, not recruiting
74 participants
Started: Jul 30, 2017 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT03274687
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
PHASE3Active, not recruiting
296 participants
Started: Jul 28, 2017 · Completed: Aug 3, 2026
4 conditions2 sponsors241 locations
NCT03136887
JOURNEY II XR Safety and Effectiveness PMCF
N/AActive, not recruiting
176 participants
Started: Jul 28, 2017 · Completed: Apr 30, 2029
6 conditions1 sponsor14 locations
NCT03269526
BATs Treatment for Pancreatic Cancer, Phase Ib/II
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jul 28, 2017 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT03181100
Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer
PHASE2Active, not recruiting
50 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2027
7 conditions2 sponsors1 location
NCT03244306
A Phase 1 Study of CD22-CAR TCell Immunotherapy for CD22+ Leukemia and Lymphoma
PHASE1Active, not recruiting
4 participants
Started: Jul 27, 2017 · Completed: Jul 31, 2035
1 condition1 sponsor1 location
NCT03264664
Study of E7386 in Participants With Selected Advanced Neoplasms
PHASE1Active, not recruiting
60 participants
Started: Jul 27, 2017 · Completed: Mar 31, 2026
1 condition1 sponsor10 locations
NCT04480242
Asthma Research in Children and Adolescents
N/AActive, not recruiting
525 participants
Started: Jul 26, 2017 · Completed: Dec 31, 2030
3 conditions1 sponsor15 locations
NCT02952508
Study of Iopofosine I 131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) and Pivotal Expansion in Waldenstrom Macroglobulinemia
PHASE2Active, not recruiting
120 participants
Started: Jul 26, 2017 · Completed: Dec 22, 2026
9 conditions1 sponsor52 locations
NCT02924857
The Chocolate Touch Study
NAActive, not recruiting
333 participants
Started: Jul 26, 2017 · Completed: Dec 31, 2026
3 conditions1 sponsor20 locations
NCT03115333
DSC-MRI in Measuring rCBV for Early Response to Bevacizumab in Patients With Recurrent Glioblastoma
NAActive, not recruiting
146 participants
Started: Jul 25, 2017 · Completed: May 7, 2027
2 conditions2 sponsors58 locations
NCT03091192
Savolitinib vs. Sunitinib in MET-driven PRCC.
PHASE3Active, not recruiting
60 participants
Started: Jul 25, 2017 · Completed: Dec 31, 2025
8 conditions2 sponsors59 locations
NCT03132454
Palbociclib and Sorafenib, Decitabine, or Dexamethasone in Treating Patients With Recurrent or Refractory Leukemia
PHASE1Active, not recruiting
32 participants
Started: Jul 25, 2017 · Completed: Dec 31, 2027
4 conditions2 sponsors1 location
NCT03089034
Singapore Cohort of Patients with Advanced Heart Failure
N/AActive, not recruiting
300 participants
Started: Jul 24, 2017 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT03141177
A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
PHASE3Active, not recruiting
701 participants
Started: Jul 23, 2017 · Completed: Jan 16, 2026
1 condition3 sponsors135 locations
NCT03094143
Early Valve Replacement Guided by Biomarkers of LV Decompensation in Asymptomatic Patients With Severe AS
NAActive, not recruiting
1,000 participants
Started: Jul 21, 2017 · Completed: Jun 30, 2032
2 conditions2 sponsors1 location
NCT04014231
Novel Single Wave Assessment in Measuring Cardiac Dysfunction and Metabolic Syndrome in Patients With Cancer
N/AActive, not recruiting
160 participants
Started: Jul 21, 2017 · Completed: May 11, 2026
1 condition2 sponsors1 location
NCT03347565
Brain Function in Adolescent Eating Disorders and Healthy Peers
N/AActive, not recruiting
155 participants
Started: Jul 21, 2017 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT02791581
Understanding and Predicting Breast Cancer Events After Treatment
NAActive, not recruiting
403 participants
Started: Jul 21, 2017 · Completed: Jul 31, 2034
1 condition2 sponsors66 locations
NCT03244176
Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study
EARLY_PHASE1Active, not recruiting
28 participants
Started: Jul 21, 2017 · Completed: Jul 31, 2025
1 condition2 sponsors3 locations
NCT02767661
Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
PHASE3Active, not recruiting
240 participants
Started: Jul 19, 2017 · Completed: May 31, 2024
1 condition1 sponsor1 location
NCT03092323
A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity
PHASE2Active, not recruiting
126 participants
Started: Jul 19, 2017 · Completed: Sep 1, 2028
1 condition3 sponsors20 locations
NCT03024489
Palbociclib With Cetuximab and IMRT for Locally Advanced Squamous Cell Carcinoma
PHASE1/PHASE2Active, not recruiting
27 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05857618
Study to Determine if Patients Exposed to General Anesthesia Significant Numbers of Times Would Increase the Risk for Intraoperative Awareness.
N/AActive, not recruiting
1,000 participants
Started: Jul 19, 2017 · Completed: Jun 1, 2027
2 conditions1 sponsor1 location
NCT03092856
Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer
PHASE2Active, not recruiting
62 participants
Started: Jul 19, 2017 · Completed: Dec 31, 2026
4 conditions2 sponsors10 locations
NCT03150329
Pembrolizumab and Vorinostat in Patients With Relapsed or Refractory DLBCL, FCL or HL.
PHASE1Active, not recruiting
52 participants
Started: Jul 18, 2017 · Completed: Jul 1, 2026
16 conditions2 sponsors1 location
NCT03173976
Anti-Osteoclast Therapy As Neoadjuvant in Treatment of Chondrosarcoma - Phase 1b Trial
PHASE1Active, not recruiting
17 participants
Started: Jul 18, 2017 · Completed: May 1, 2028
1 condition2 sponsors1 location